E-Cigarette Maker Juul Eyes Strategic Alternatives With Philip Morris, Japan Tobacco, Altria
E-Cigarette Maker Juul Eyes Strategic Alternatives With Philip Morris, Japan Tobacco, Altria
電子煙製造商 Juul 眼睛與菲利普·莫里斯,日本煙草,Altria 的戰略替代品
- Lately, e-cigarette maker Juul Labs Inc had separate discussions with Philip Morris International Inc (NYSE:PM), Japan Tobacco (OTC:JAPAF) (OYTC: JAPAY), and Altria Group, Inc (NYSE:MO) over a potential sale, investment or partnership.
- Altria, which owns a 35% stake in Juul, valued the vaping company at $1 billion in October, the Wall Street Journal reports.
- Juul, which represents 27% of e-cigarettes sold in U.S. stores tracked by Nielsen, was on the verge of bankruptcy in 2022 amid a regulatory dispute over its existence in the U.S. market.
- The U.S. pursued a federal ban on menthol cigarettes. California has already banned menthols.
- The U.S. proceeded to eliminate nearly all nicotine from cigarettes.
- As federal regulators revamped the industry, big tobacco companies competed to grab pieces of the U.S. e-cigarette market.
- The FDA in June ordered Juul to halt its U.S. sales which neared the settlement of lawsuits accusing it of marketing its products to children and teens.
- Juul reached talks with Altria last fall on a potential deal to sell Juul's international business or license its U.S. intellectual property. Still, those talks fell apart in September as Juul prepared for a possible bankruptcy.
- Last September, Altria shared plans to end the agreement with Juul, which helped the latter prepare for its sale.
- In January, Juul CEO K.C. Crosthwaite and other executives traveled to Switzerland, where Japan Tobacco and Philip Morris are based, to discuss Juul's newly expanded option.
- Juul has also resumed discussions with Altria. Altria cannot buy Juul outright over antitrust concerns.
- If the FDA ultimately halts Juul's sales, Juul could seek U.S. authorization for a newer version of its vaporizer released in Canada and the U.K.
- Price Action: MO shares traded higher by 0.11% at $44.98 in the premarket on the last check Thursday.
- 最近,電子煙製造商 胡爾實驗室公司 與之進行了單獨討論 菲利普·莫里斯国际 (紐約時間:下午), 日本煙草 (OTC: 日本) (OYTC: 日本), 和 奧特利亞集團股份有限公司 (NYSE: MO) 關於潛在的銷售、投資或合作關係。
- 華爾街日報報導,奧爾特里亞(Altria)擁有 Juul 的 35% 股份,在 10 月份以 10 億美元的價格估值了這家電子煙公司。
- Juul 代表尼爾森跟踪在美國商店銷售的 27% 的電子煙,在 2022 年處於破產邊緣,因為其在美國市場存在的監管爭議。
- 美國追求聯邦禁止薄荷醇香煙。加州已經禁止了薄荷。
- 美國繼續從香煙中消除幾乎所有尼古丁。
- 隨著聯邦監管機構改造該行業,大型煙草公司競爭奪美國電子煙市場的一部分。
- FDA 於 6 月下令 Juul 停止其美國銷售,該銷售接近指控其向兒童和青少年銷售其產品的訴訟的解決。
- Juul 去年秋天與 Altria 就出售 Juul 的國際業務或授權其美國知識產權的潛在交易進行了會談。儘管如此,隨著 Juul 為可能的破產做好準備,這些會談在 9 月份崩潰。
- 去年九月,阿爾特里亞(Altria)分享了與 Juul 結束協議的計劃,該協議幫助後者準備出售。
- 今年 1 月,Juul 首席執行官 K.C. Crosthwaite 和其他高管前往日本煙草公司和菲利普·莫里斯所在的瑞士,討論了 Juul 新擴展的選擇。
- Juul 還恢復了與阿爾特里亞的討論。 阿爾特里亞不能直接購買 Juul 在反壟斷擔憂.
- 如果 FDA 最終停止了 Juul 的銷售, Juul 可以尋求美國. 授權在加拿大和英國發布的其蒸發器的新版本.
- 價格行動: 上次檢查週四,MO 股價上漲 0.11%,報 44.98 美元。